ERMARD

Model summary

A soluble human RNA-handling scaffold that assembles ribonucleoprotein complexes for RNA surveillance and processing. It uses a bipartite architecture to bind RNA and recruit partner proteins, channeling transcripts toward decay pathways and transiently engaging tRNA repair assemblies. The complex operates in both nucleoplasm and cytoplasm, where it organizes RNA quality-control hubs and coordinates with RNA-processing machinery through multivalent interactions rather than intrinsic catalysis.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The polypeptide is covered end-to-end by IPR039635 (Endoplasmic reticulum membrane-associated RNA degradation protein family, residues 1–664), establishing membership in the EMARD family. Within this scaffold, the N-terminal half is defined by IPR025209 (EMARD N-terminal domain, residues 12–404), followed by a linker and then IPR063699 (EMARD C-terminal domain, residues 432–658). This bipartite N- then C-terminal EMARD arrangement creates a modular platform: the extended N-terminal domain typically mediates RNA and protein contacts, while the compact C-terminal domain stabilizes higher-order assemblies and membrane-proximal positioning. The ordered layout—large N-terminal interaction module feeding into a C-terminal assembly module—causally supports multivalent binding and RNA-handling functions rather than enzymatic catalysis.

2. 02

   From this architecture, the molecular function resolves into two complementary activities.

   First, the broad EMARD family scaffold and the extensive N-terminal domain favor GO:0005515 protein binding; such platforms commonly nucleate ribonucleoprotein complexes and recruit decay machinery. Second, the EMARD N-terminal domain’s propensity for nucleic acid association and the family’s role in RNA turnover justify GO:0003723 RNA binding. Together, these features cause the protein to act as an RNA-interacting adaptor that binds both RNA and partner proteins to choreograph RNA fate.

3. 03

   These molecular activities propagate into two biological processes.

   The EMARD family is tightly coupled to RNA quality control and decay, and the architecture is suited to funnel aberrant transcripts toward degradation pathways. In parallel, the presence of GO:0006388 tRNA splicing, via endonucleolytic cleavage and ligation is mechanistically coherent: endonuclease–ligase pathways for tRNA repair also generate structured intermediates and RNP assemblies that benefit from RNA-binding scaffolds. Thus, the same binding and assembly logic that drives RNA decay can stabilize or triage tRNA processing complexes.

4. 04

   Cellular localization follows from the domain logic and known topological cues.

   The absence of transmembrane helices and the presence of large soluble interaction domains argue for a soluble pool. The protein is reported in the cytoplasm and nucleoplasm, and the soluble EMARD scaffold readily explains nucleoplasmic residence (GO:0005654 nucleoplasm) where pre-mRNA and tRNA processing assemblies form. Cytoplasmic pools are expected as well, consistent with RNA surveillance and decay that often occurs in cytoplasmic RNP granules.

5. 05

   Mechanistically, I hypothesize that the N-terminal EMARD domain captures target RNAs and recruits decay and processing factors, while the C-terminal domain stabilizes higher-order assemblies and positions the complex near ER-proximal RNA quality-control hubs even if the protein itself remains soluble.

   Likely partners include ER-associated RNA decay adaptors and ribosome-associated factors that flag problematic transcripts. In the nucleus, the same scaffold can transiently engage tRNA repair machinery, explaining the linkage to endonucleolytic cleavage and ligation. Overall, the EMARD N→C architecture drives multivalent RNA/protein binding that routes RNAs toward surveillance and processing pathways in both nucleoplasm and cytoplasm.